Generali Asset Management SPA SGR
Position in TMO — Thermo Fisher Scientific Inc.
CIK 2046751
TRIESTE, L6
Position in TMO
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$9,250,092
+$844,438 QoQ
Shares Held
18,450
+7.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#667
of 2,602 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Generali Asset Management SPA SGR holds $50,673,741 across 12 Diagnostics & Research names. TMO ranks #2 (18.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
64,292 | $12,246,340 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
18,450 | $9,250,092 | |
| 3 | A |
Agilent Technologies, Inc.
|
51,783 | $6,878,335 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
33,926 | $6,555,181 | |
| 5 | LH |
Labcorp Holdings Inc.
|
15,711 | $4,399,080 | |
| 6 | DGX |
Quest Diagnostics Inc
|
15,146 | $3,210,194 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
5,860 | $3,084,938 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
1,642 | $2,097,671 |
All Filings in TMO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,250,092 | 18,450 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $8,405,654 | 17,101 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $12,195,684 | 21,047 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $8,119,234 | 16,740 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $6,682,791 | 16,482 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $9,488,236 | 19,068 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,158,767 | 15,683 | Shares | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||